IB Pharmaceuticals Inc. — Form D
IB Pharmaceuticals Inc. of RALEIGH, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-12. The offering totals $4.8M, of which $4.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-02-12
- Form: D
- Accession: 0001666690-18-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $4.8M
- Investors: 1
- Date of first sale: 2018-01-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-305380
Issuer
- Name: IB Pharmaceuticals Inc.
- CIK: 0001666690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 8480 HONEYCUTT ROAD, RALEIGH, NC, 27615
- Phone: 919-275-1933
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Sandeep Laumas | Director | Greenwich, CT |
| Sandeep Laumas | Executive Officer | Greenwich, CT |
| Jay Madan | Director | Raleigh, NJ |
| Jay Madan | Executive Officer | Raleigh, NJ |
| Jay Madan | Promoter | Raleigh, NJ |
| Christopher Prior | Executive Officer | Raleigh, NC |
| Chris Prior | Executive Officer | Raleigh, NC |
| Christopher P Prior | Executive Officer | Raleigh, NC |
| Kendyle Woodard | Executive Officer | Raleigh, NC |
Other filings by this issuer (5)
More